Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-07-12
2010-02-16
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S403000, C548S300100, C548S356100
Reexamination Certificate
active
07662844
ABSTRACT:
Compounds of the formulaand pharmaceutically acceptable salts thereof, wherein n1, n2, n3, n4, G1, Q1, Z, R1, R2, R3, R4a, R4b, R5a, and R5bare defined herein, inhibit the cytochrome P450RAI enzyme and are useful for the treatment and/or prevention of various diseases and conditions which respond to treatment by retinoids and by naturally occurring retinoic acid.
REFERENCES:
patent: 4734406 (1988-03-01), Lau et al.
patent: 4876354 (1989-10-01), Siegel
patent: 5023357 (1991-06-01), Siegel
patent: 5100890 (1992-03-01), Siegel
patent: 909357 (1962-10-01), None
patent: 1122756 (1968-08-01), None
patent: 06263742 (1994-09-01), None
patent: WO9408973 (1994-04-01), None
patent: WO9954309 (1999-10-01), None
patent: WO0102373 (2001-01-01), None
patent: WO0130762 (2001-05-01), None
patent: WO2005007631 (2005-01-01), None
Li, Xingshu et al. (2004) Acta Crystallographica, E59(5): 0706-0707.
Wahler, Denis et al (2002) Chemistry—European Journal, 8(14): 3211-3228.
Shibata, Tomoyuki et al. Database Caplus ‘Online’—Chemical Abstracts Service, Columbus, Ohio, US. ‘Preparation of (cyanobenzyl) azole derivatives as aromatase inhibitors’ retreived from STN Database accession No. 1995:513524. (from International Search Report PCT/US2004/022282).
International Search Report in PCT/US2004/022282.
Written Opinion of the International Searching Authority in PCT/US2004/022282.
International Preliminary Report On Patentability in PCT/US2004/022282.
Beck Patricia Anne
Castelhano Arlindo L.
Cesario Cara
Mulvihill Mark
Nigro Anthony
Chung Susannah
OSI Pharmaceuticals Inc.
OSI Pharmaceuticals, Inc.
Rafa Michael J.
Shameem Golam M. M.
LandOfFree
Naphthylene derivatives as cytochrome P450 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Naphthylene derivatives as cytochrome P450 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Naphthylene derivatives as cytochrome P450 inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4225464